CX-801

N/A

Report date: 2024/05/17 16:18:18

Base Information

Drug NameCX-801
Drug Alias NameCX-801
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha-2 replacements
TargetsInterferon alpha-2
Therapy Area/IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCytomx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCytomx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursSquamous Cell Carcinoma of Head and NeckCarcinoma, Renal Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A